AlphaYouAB
Schedule 13D filing
AH Bio Fund II, L.P. disclosed a 6% stake in Nautilus Biotechnology, Inc. (NAUT)
AH Bio Fund II, L.P. reported owning 6% of Nautilus Biotechnology, Inc. (NAUT) (7,684,932 shares) in a Schedule 13D filed Aug 28, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Aug 28, 2026
- Source
- Schedule 13D
More NAUT insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.